News

  • 12 March 2019

    Janssen’s UNIFI trial of Stelara meets primary endpoint

    Janssen Pharmaceutical has reported positive results from the Phase III UNIFI clinical trial of subcutaneous (SC) Stelara (ustekinumab) as a maintenance therapy in adults with moderate to severe ulcerative colitis...

  • 11 March 2019

    Takeda reports positive Phase IIIb results for vedolizumab

    Takeda Pharmaceutical has reported positive results from the Phase IIIb head-to-head VARSITY clinical trial of gut-selective biologic vedolizumab (Entyvio) for the treatment of moderately to severely active ulcerative colitis (UC).

  • 8 March 2019

    Zynerba initiates Phase II CBD gel trial for autism

    Zynerba Pharmaceuticals has initiated a Phase II clinical trial of its cannabinoid (CBD) gel Zygel (ZYN002) for the treatment of children and adolescents with autism spectrum disorder (ASD).

Close
Close
Close

Go Top